Skip to main content
. 2022 Jan 24;22:87. doi: 10.1186/s12879-022-07069-z

Fig. 5.

Fig. 5

Effects of the age and the sex of the subject, and the time-period between the vaccination and the measurement on the probability of the lack of RBD-specific antibody production (titre below 1, left panel) and of low antibody titre (titre below 10, right panel) after two doses of the Sinopharm vaccine. 90% credible interval is shown for males, 28 days post second dose (credible intervals for the other curves are not shown for visual clarity, as they are very similar)